Ginkgolic acid

Ginkgolic acid is a phenolic alkylphenol compound found in Ginkgo biloba leaves and seeds that exerts anti-inflammatory effects primarily by inhibiting microsomal prostaglandin E2 synthase-1 (mPGES-1) with an IC50 of 0.7 µM. It also suppresses 5-lipoxygenase activity and demonstrates anti-tyrosinase properties relevant to skin depigmentation research.

Origin & History

Ginkgolic acid is a phenolic acid and salicylic acid derivative found in Ginkgo biloba L. It features a hydroxybenzoic acid core with long-chain alkyl or alkenyl groups, making it lipophilic. Its molecular formula varies with chain length, such as C22H34O3 for the C15:1 variant.

Historical & Cultural Context

The research does not provide details on the historical or traditional use of ginkgolic acid in any traditional medicine system.

Health Benefits

• Inhibits mPGES-1, a key inflammatory mediator (IC50 = 0.7 µM) [4]. • Exhibits anti-tyrosinase activity in vitro (IC50 = 2.8 mg/mL) [2]. • Demonstrates neuroprotective properties, although specific mechanisms need further study [4]. • Shows inhibitory activity against 5-lipoxygenase, involved in pro-inflammatory lipid mediator synthesis [4]. • Possesses antimicrobial and antitumoral properties, with mechanisms not fully elucidated [4].

How It Works

Ginkgolic acid inhibits mPGES-1 (microsomal prostaglandin E2 synthase-1) at an IC50 of 0.7 µM, reducing downstream prostaglandin E2 synthesis and dampening the arachidonic acid inflammatory cascade. It also suppresses 5-lipoxygenase (5-LOX), an enzyme that converts arachidonic acid into pro-inflammatory leukotrienes such as LTB4. Additionally, its anti-tyrosinase activity (IC50 = 2.8 mg/mL) involves competitive inhibition of the copper-containing enzyme tyrosinase, blocking melanin biosynthesis from L-DOPA.

Scientific Research

There are no available human clinical trials or meta-analyses evaluating ginkgolic acid in clinical populations. The research focuses primarily on in vitro studies exploring biochemical mechanisms.

Clinical Summary

Current evidence for ginkgolic acid is largely confined to in vitro cell-based and enzymatic assays; robust human clinical trials are absent. In vitro studies demonstrate potent mPGES-1 inhibition and 5-LOX suppression, suggesting a dual anti-inflammatory mechanism comparable to some NSAIDs at the enzyme level. Neuroprotective effects have been observed in cell models, though the precise molecular targets and pathways remain incompletely characterized. The overall evidence base is preliminary, and extrapolation of in vitro IC50 values to human therapeutic doses requires significant caution.

Nutritional Profile

Ginkgolic acid is a bioactive alkylphenol compound (not a conventional nutrient), so it lacks a traditional macronutrient or micronutrient profile. Key chemical identity: it is a mixture of homologs differing in alkyl side-chain length (C13:0, C15:1, C17:1 being most prevalent), with molecular weights ranging approximately 346–390 g/mol. It is a lipophilic phenolic acid derivative structurally related to anacardic acids. Bioactive compound concentration in Ginkgo biloba leaf extracts typically ranges from trace levels up to 0.04–0.06% in raw leaf material; pharmaceutical-grade standardized Ginkgo extracts are regulated to contain <5 ppm (0.0005%) ginkgolic acids due to toxicity concerns (European Pharmacopoeia limit). No meaningful fiber, protein, carbohydrate, or conventional vitamin/mineral content is associated with this isolated compound. Bioavailability: highly lipophilic (logP estimated ~5–7), suggesting good passive membrane permeability but potential for protein binding and accumulation; oral bioavailability data in humans is limited. It is not considered a nutrient but rather a secondary plant metabolite with pharmacological and toxicological relevance. Protein content: not applicable. Fiber: not applicable. Caloric value: negligible at biologically relevant concentrations.

Preparation & Dosage

No clinically studied dosage ranges or standardized extract concentrations for ginkgolic acid in human use are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Resveratrol, Quercetin, Omega-3 fatty acids, Green tea extract

Safety & Interactions

Ginkgolic acids are classified as potentially toxic allergens and are tightly regulated in standardized Ginkgo biloba extracts, with the European Pharmacopoeia limiting total ginkgolic acid content to below 5 ppm due to cytotoxic and sensitizing properties. High concentrations have demonstrated cytotoxicity in cell studies, including potential DNA damage and inhibition of SUMOylation, a critical protein-regulation process. Ginkgolic acid may potentiate the effects of anticoagulants such as warfarin by modulating arachidonic acid metabolism, increasing bleeding risk. Pregnant and breastfeeding women should avoid products with elevated ginkgolic acid content, and individuals with known nut or Ginkgo allergies face heightened sensitization risk.